Thromboprophylaxis May Not Benefit Patients With Advanced Cancer in Palliative Care
Thromboprophylactic treatment and serum albumin levels were not found to be associated with deep vein thrombosis incidence.
Thromboprophylactic treatment and serum albumin levels were not found to be associated with deep vein thrombosis incidence.
Researchers conducted a systematic literature review to characterize the complications experienced by patients with upper extremity deep vein thrombosis.
No differences were observed in patency rates or incidence of post-thrombotic syndrome in patients treated with rivaroxaban or a vitamin K antagonist.
The incidence, pathophysiology, provoking factors, and recommended treatments for several types of unusual thrombosis were summarized in a review article.
A number of risk factors were associated with chronic thromboembolic pulmonary hypertension, including, age >70 years, female gender, and pulmonary embolism at first venous thromboembolism.
The Society of Radiologists in Ultrasound has endorsed recommendations regarding ultrasound imaging test protocols for patients with suspected deep venous thrombosis.
Incidence risk is lower with first superficial vein thrombosis after stopping anticoagulant therapy compared to those with proximal deep vein thrombosis.
Patients experienced an elevated risk of venous thromboembolism both immediately before and immediately after giant cell arteritis diagnosis.